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Available online xxxxThe aim of this work was an investigation of the physical changes of the amorphous model material spray-dried
trehalose through the use of various analytical techniques and to identify a suitable, rapid method able to quan-
tify the changes. The crystallinity changes and recrystallization process of amorphous samples were investigated
by hot-humidity stage X-ray powder diffractometry (HH-XRPD)with fresh samples, conventional X-ray powder
diffractometry (XRPD) used stored samples and by differential scanning calorimetry (DSC). The data from the
three methods were compared and the various forms of trehalose were analysed. HH-XRPD demonstrated that
the recrystallization began at 40 and 60 °C up to 45% RH and at 70 °C up to 30% RH into dihydrate form. At
70 °C up to 60% RH the anhydrous form of trehalose appeared too. Conventional XRPD results showed, that in
the 28 days stored samples the dihydrate form was detected at 40 °C, 50% RH. Storage at 60 °C, 40% RH resulted
in the appearance of the anhydrous form and at 60 °C, 50% RH both polymorphic forms were detected. By carry-
ing out the DSC measurements at different temperatures the fraction of recrystallized trehalose dihydrate was
detected. The recrystallization investigated by HH-XRPD and DSC followed Avrami kinetics, the calculated rate
constants of isothermal crystallization (K) were same. Both HH-XRPD and conventional XRPD was suitable for
the detection of the physical changes of the amorphous model material. DSC measurements showed similar re-
sults as HH-XRPD. Primarily HH-XRPD could be suggested for prediction, because the method is fast and every
changes could be studied on one sample.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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DSC1. Introduction
Trehalose is a natural sugar, but it is also synthesized and produced
on a large scale industrially. It is widely applied in the cosmetic, agricul-
tural, food and drug industries. In drug formulations, it is utilized as an
active pharmaceutical ingredient or as a technological auxiliary agent.
Trehalose could be also an active agent as chemical chaperone which
is used to treat Creutzfeldt-Jakob disease, cystic ﬁbrosis and amyloid
disorders that prevent protein aggregation (Aguib et al., 2009). In oral
medication, it displays antidepressant properties in the mouse model
of depression, possibly through reducing the p62/Beclin-1 ratio and in-
creasing autophagy in the frontal cortex (Kara et al., 2013).
The most important applications of trehalose as a pharmaceutical
excipient are to preserve enzymes, to stabilize vaccines at room temper-
ature for storage, and to protect mammalian cells from damage during
lyophilization. Trehalose concentrates the water near the protein, and
it can be transformed to its native structure after lyophilization and re-
gain its function (Timasheff, 2002). The protein-stabilizing ability oftical Technology, University of
rt-Laczkovich).
., et al., Investigation of recry
rmaceutical Sciences (2016),trehalose is utilized in many areas of industry, e.g. as a moisturizer or
to stabilize liposomes (Tanaka et al., 1992). As an auxiliary component,
it is often applied as a carrier of dry powder inhalation (DPI) systems.
For this purpose, α-lactose monohydrate is normally used, but lactose
may reactwith the amino group, so proteins andpeptides cannot be for-
mulated with it. In this case, lactose must be substituted with trehalose,
rafﬁnose or sucrose. These non-reducing sugars have the common ad-
vantage of protecting proteins or peptides against different stress condi-
tions during spray-drying. They substitute the hydrogen-bonds in
water, and form viscous mixtures with proteins, resulting in products
with high glass temperatures of the product (Maas et al., 2011).
Trehalose is often produced as an excipient by spray-drying (Ógáin
et al., 2011; Islam and Gladki, 2008; Gradon and Sosnowski, 2014;
Pomázi et al., 2011; Maurya et al., 2005a; Maurya et al., 2005b; Moran
and Buckton, 2007a; Amaro et al., 2015), freeze-drying (Murugappan
et al., 2013; Nakamura et al., 2008; Crowe et al., 2003; Jovanovoc et al.,
2006; Claus et al., 2011) and spray-freeze-drying (Tonnis et al., 2014;
Yu et al., 2006) in pharmaceutical technology. Trehalose tends to under-
go amorphization, and the amorphous form is readily prepared by using
a solvent method such as spray- or freeze-drying. The recrystallization
kinetics can be followed which is important because of the appearance
of polymorph forms (Sussich and Cesáro, 2008). Trehalose has 4stallization of amorphous trehalose through hot-humidity stage X-ray
http://dx.doi.org/10.1016/j.ejps.2016.08.003
Table 1
Melting points of trehalose polymorphs (Sussich and Cesáro, 2008).
Polymorph Melting point (°C)
Trehalose-α (anhydrous) 120
Trehalose-β (anhydrous) 215
Trehalose-γ (anhydrous) 118–122
Trehalose-h (dihydrate) 100–110
Table 3
Different storage conditions of amorphous samples.
Temperature (°C) Relative humidity (%) Storage time (day)
25 ± 2 32 ± 5 1
40 ± 2 30 ± 5 28
40 ± 5 28
50 ± 5 28
60 ± 2 30 ± 5 28
40 ± 5 28
50 ± 5 28
2 O. Jójárt-Laczkovich et al. / European Journal of Pharmaceutical Sciences xxx (2016) xxx–xxxpolymorphic forms (Table 1). This is especially important in the case of
DPI because of the preparation methods and the storage conditions of
the product. In this work one of the most efﬁcient amorphization tech-
nology, spray-drying was selected for preparing amorphous trehalose.
This method results in a monodisperse product with suitable particle
size and excellent ﬂowability.
Various analytical methods are available to investigate
amorphization (Jójárt-Laczkovich and Szabó-Révész, 2010;
Jójárt-Laczkovich and Szabó-Révész, 2011; Danciu et al., 2014; Jug and
Bećirević-Laćan, 2004), recrystallization, polymorphic conversions,
and the dehydration and rehydrationmechanisms of differentmaterials
(Szakonyi and Zelkó, 2012). Common techniques are differential scan-
ning calorimetry (DSC) and X-ray powder diffraction (XRPD) measure-
ments. Besides these possibilities, dynamic vapour sorption (Jones et al.,
2006), Karl Fischer moisture titration, isothermal thermogravimetric
analysis (Taylor and York, 1998) and simultaneous techniques (DSC-
XRPD and TG-DTA) have also been described in the case of trehalose
(Furuki et al., 2005; Mah et al., 2015). A modern investigation method
is hot-humidity stage X-ray powder diffraction (HH-XRPD), whereby
temperature and RH are variable. Through HH-XRPD analysis, complex
pharmaceutical solid-state reactions, including crystal structure trans-
formations, can be in situ characterized and followed. This method rap-
idly provides information about polymorph conversions and
recrystallization kinetics, and short-term stability testing can be carried
out during preformulation studies. Examples of the polymorphic trans-
formation of some active and auxiliary agents (naloxone, naltrexone
and aspartame) are to be found in the literature (Guguta et al., 2009;
Guguta et al., 2008).
The focus of this work was an investigation of the recrystallization
process of the amorphous model material spray-dried trehalose and to
ﬁnd a suitable method to predict the recrystallization of amorphous
sample during a preformulation study. In a comparison study three, dif-
ferent methods (HH-XRPD, XRPD, DSC) were used to analyse the crys-
tallinity changes.2. Materials and methods
2.1. Materials
D-(+)-trehalose dihydrate h-form was purchased from Karl Roth
GmbH+ Co. KG. (Karlruhe, Germany). This was regarded as 100% crys-
tallinematerial. Thewater contentwas 9.5±0.5% and the sulphate con-
tent was b0.5%. Its speciﬁc rotation was 178 ± 2°.
Anhydrous D-(+)-trehalose β-form was produced by dehydration
of trehalose dihydrate at 85 °C during 4 h under vacuum (Nagase
et al., 2002) and checked the within 24 h both with DSC and XRPD.Table 2
Operation parameters for the preparation of spray-dried trehalose.
Operating parameters Settings
Inlet temperature (°C) 130–140
Outlet temperature (°C) 75–92
Feed rate (ml/min) 2
Pressure (bar) 4,8
Atomizer ﬂow rate (normolitre/h) 600
Aspirator (%) 80
Please cite this article as: Jójárt-Laczkovich, O., et al., Investigation of recry
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Trehalose dihydrate was spray-dried from 10% solutions in water
(5 g of trehalose and 45 g of water), using a Büchi 191 Mini Spray
Dryer (Büchi, Switzerland). The parameters used are given in Table 2
(Moran and Buckton, 2007b). The spray-dried products were stored in
a desiccator over cobalt(II) chloride-contaminated silicon dioxide
(25 ± 2 °C, 32 ± 5% RH) until use and were X-ray amorphous.
2.3. Preparation of physical mixtures
Physical mixtures of spray-dried (amorphous) and the two different
crystalline form of trehalose were prepared to achieve 0, 5, 10, 30, 50,
70, 90, 95 and 100% crystalline content by mass. The components
were weighed to a total amount of 0.50 g andweremixed homogenous
in a trituration mortar.
2.4. HH-XRPD
HH-XRPD analysis was performed on the spray-dried amorphous
sampleswithin 24 h by using a Bruker D8 Advance X-rayDiffractometer
(Bruker AXS GmbH, Karlsruhe, Germany) with Cu K λI radiation (λ=
1.5406 Å) installed with an MRI Basic hot-humidity stage and a
VÅNTEC-1 detector. The samples were scanned at 40 kV and 40 mA.
The angular range was from 3° to 40° 2θ, at a step time of 0.1 s and a
step size of 0.007°. An ANS-Sycoshot humidity control device was
coupled to the XRPD, which injected humidity into a controlled dry
gas ﬂow. The carrier gas was compressed air with a 0.5 l/min ﬂow.
The sample was taken in a Ni-coated sample holder. The RH was set at
10, 20, 30, 40, 45, 50, 60 and 70% at 40 °C, 60 °C and 70 °C controlled
temperatures, and the samples were kept in each condition for 1 h be-
fore measurement. All manipulations, Kα 2-stripping, background re-
moval and signal to noise smoothing of the area under the peaks of
diffractograms were performed with DIFFRACTPLUS EVA software.
2.5. XRPD
XRPD analysis was performedwith a Bruker D8Advance diffractom-
eter (Bruker AXS GmbH, Karlsruhe, Germany) with Cu K λI radiation
(λ= 1.5406 Å) and a VÅNTEC-1 detector. Both the physical mixtures
and the stored amorphous samples were scanned at 40 kV and 40 mA.
The angular range was 3° to 40° 2θ, at a step time of 0.1 s and a step
size of 0.007°. The sample was placed on a quartz holder, measured at
ambient temperature and RH. All manipulations, Kα 2-stripping, back-
ground removal and smoothing of the area under the peaks of
diffractograms were performed with DIFFRACTPLUS EVA software. The
determination of the polymorph form was based on the Cambridge
Crystallographic Data Centre (CCDC ID: AI631510) X-ray powder
diffractograms.
2.6. Storage conditions
One part of the spray-dried product was stored in a desiccator over
cobalt(II) chloride-contaminated silicon dioxide (25 ± 2 °C, 32 ± 5%stallization of amorphous trehalose through hot-humidity stage X-ray
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Fig. 1. Relation between predicted and actual crystallinity of physical mixtures of crystalline trehalose dihydrate - amorphous form (A), anhydrous trehalose - amorphous form
(B) determined by conventional X-ray powder diffraction.
3O. Jójárt-Laczkovich et al. / European Journal of Pharmaceutical Sciences xxx (2016) xxx–xxxRH) until HH-XRPD measurements. The reminder was divided into 6
parts and stored for 28 days at 40 °C and 60 °C, in 3-3 hygrostats,
where the RH was set to 30%, 40% and 50% RH. In each dessicator and
hygrostates, there was a digital humidity meter during the storage for
controlling the relative humidity. These samples were investigated
with XRPD (Table 3).
2.7. Calculation of the recrystallization kinetics
The recrystallization kinetics was modelled by using the Avrami
equation (Eq. (1)):
1−α ¼ exp −Ktnð Þ ð1Þ
where α is the fraction of recrystallized trehalose at time t, K is the rate
constant and n is the Avrami index, a parameter characteristic of the nu-
cleation and growth mechanism of crystals.
The fraction of recrystallized trehalose (α) was calculated from the
area under the characteristic peaks using the following equation
(Eq. (2)):
α ¼ Acrystalline
Acrystalline þ Aamorphous
100 ð2Þ
whereα is the crystalline fraction, A is the area of characteristic crystal-
line peaks and amorphous sign. Three characteristic peaks eachwere se-
lected from the diffractograms of trehalose dihydrate (at 8.531°, 12.552°
and 14.224° 2θ) and anhydrous trehalose (at 6.572°, 20.351° and
24.792° 2θ). The XRPD instrumentwas calibrated every daywith corun-
dum during the 28 days measurement to minimalize the day to day in-
tensity changes in XRPD emission.Table 4
The degree of crystallinity calculated from the HH-XRPD data (A: amorphous, h-form:
dihydrate, β-form: anhydrous).
Time [min, RH%] Form of trehalose Degree of crystallinity
(%)
40 °C 60 °C 70 °C 40 °C 60 °C 70 °C
0, 0 A A A 0 0 0
60, 10 A A A 0 0 0
120, 20 A A A 0 0 0
180, 30 A A h-form 0 0 11.7
240, 40 A A h-form 0 0 31.1
300, 45 h-form h-form h-form 14.8 27.2 65.2
360, 50 h-form h-form h-form 35.8 62.4 100
420, 60 h-form h-form β/h-form 70.2 78.8 100
480, 70 h-form h-form β/h-form 100 100 100
Please cite this article as: Jójárt-Laczkovich, O., et al., Investigation of recry
powder diffraction, European Journal of Pharmaceutical Sciences (2016),The Avrami parameters were obtained from the experimental data
by using the double logarithmic form of Eq. (1):
ln − ln 1−αð Þ½  ¼ lnK þ n lnt ð3Þ
The activation energy of the recrystallizationwas calculated by using
the Arrhenius equation (Eq. (4)):
k ¼ k0 exp − EaRT
 
ð4Þ
In the model, k is the rate constant at temperature T, k0 is the fre-
quency factor, R is the gas constant and Ea is the activation energy. The
logarithmic form of Eq. (4) allows determination of the activationFig. 2. The recrystallized trehalose polymorphs at 40, 60 and 70 °C controlled
temperatures.
stallization of amorphous trehalose through hot-humidity stage X-ray
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Fig. 3. Crystallization kinetics by ﬁtting the Avrami equation to the HH-XRPD data.
Fig. 5. Top-viewpictures of XRPD investigations of samples stored for 28 days at 40 °C, 50%
RH (A), 60 °C, 40% RH (B) and 60 °C, 50% RH (C).
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lnk ¼ lnk0− EaRT ð5Þ
2.8. DSC
DSCmeasurementswere carried outwith aMettler-Toledo 821e DSC
instrument (Mettler-Toledo GmbH, Switzerland). Samples loaded at
different RH (10, 20, 30, 40, 45, 50 and 70%) in the XRPD humidity
chamber for 1 h were crimped in aluminium pans with three holes
and were examined in the temperature interval 25–250 °C at a heating
rate of 10 °Cmin−1 under a constant argon ﬂow of 150mlmin−1. Every
measurement was normalized to sample size. The fraction of recrystal-
lized trehalose dihydrate was calculated from the integral of sharp en-
dotherm at 108 °C.
3. Results and discussion
3.1. Determination of calibration curves with XRPD
The peak intensities of the individual components are proportional
to the quantities of components in the mixture. Three characteristic
peaks eachwere selected from thediffractogramsof trehalose dihydrate
(at 8.531°, 12.552° and 14.224° 2θ) and anhydrous trehalose (at 6.572°,
20.351° and 24.792° 2θ). Multiple linear regression (MLR) was used to
determine the calibration curve. The dependent variable was the crys-
tallinity and the independent variables were the relative intensity
values at chosen 2θ values. After determination of the degree of crystal-
linity from w/w ratio of the physical mixtures, a calibration curve was
ﬁtted. Linear regression of the data produced an r2 = 0.995 and a
slope of 0.990 for trehalose dihydrate (Fig. 1A). For anhydrous trehalose,
r2 = 0.997 and the slope was 0.997 (Fig. 1B).Fig. 4. Determination of the Avrami parameters n and K from HH-XRPD data.
Please cite this article as: Jójárt-Laczkovich, O., et al., Investigation of recry
powder diffraction, European Journal of Pharmaceutical Sciences (2016),Because of the well-correlating r2 values the degree of crystallinity
can be quantiﬁed.
3.2. Calculation of crystallization kinetics
3.2.1. Hot-humidity stage XRPD analysis
For the development and qualiﬁcation of solid compositions it is im-
portant to investigate and determine changes of the crystalline phases
or the effect of crystallization inhibitor, when materials are exposed to
changing humidity and temperature. Increasing the humidity in small
intervals (10%) at the exact temperature, good estimation could be
gained during fewhours at the exact temperature about the samples be-
haviour,which could be reﬂected on the results of conventional stability
test. There is no need for additional hygrostats and extra samples, the
measurement takes place directly in the chamber conducted to the in-
strument. These investigations are not only important to establish pro-
cedures for storage, production and shipment, but also emulate the
indigestion of the respective drug and its ﬁrst interactions with thestallization of amorphous trehalose through hot-humidity stage X-ray
http://dx.doi.org/10.1016/j.ejps.2016.08.003
Fig. 6. Diffractograms of samples stored for 28 days under different conditions, compared
with trehalose forms in CCDC.
Table 6
ΔH ofmelting and the crystalline fraction (α) at different temperatureswith increasing the
RH.
ΔH (J g−1) α (%)
RH (%) 40 °C 60 °C 70 °C 40 °C 60 °C 70 °C
30 – – 17.1 0 0 11
40 – – 27.3 0 0 17.6
45 44.5 33.0 128.1 28.7 21.3 82.7
50 63.8 66.0 137.6 41.2 42.6 88.8
60 130.4 123.5 141.4 84.2 79.7 91.3
70 153.5 153.0 153.8 99.1 98.8 99.3
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crystallization, which is presented in Table 4.
The samples measured at 40 and 60 °C were amorphous up to 45%
RH,when recrystallization began in the trehalose dihydrate polymorph.
The samples measured at 70 °C were amorphous up to 30% RH, than
they recrystallized to dihydrate form and up to 60% RH the anhydrous
form appeared too. The determination of the polymorph forms was
based on the Cambridge Crystallographic Data Centre (CCDC ID:
AI631510) X-ray powder diffractograms (Fig. 2).
The diffractogramsmeasured at 40, 60 and 70 °C showed an increas-
ing tendency to recrystallization. The relative intensities and integrals of
the peaks increased with the temperature, and the temperature there-
fore inﬂuences the tendency of trehalose to recrystallize.
To investigate the temperature dependence of recrystallization, the
recrystallized fractions were plotted against time for each temperature.
As the calibration showed, before XRPD the method could be used for
quantitative measurements. The curves obtained by ﬁtting the AvramiTable 5
The degree of crystallinity calculated from the XRPD data after 28 days.
Condition [°C, RH%] Form of trehalose
Amorphous Dihydrate (h-form) Anhydrous (β
40, 30 + − −
40, 40 + − −
40, 50 + + −
60, 30 + − −
60, 40 + − +
60, 50 + + +
Please cite this article as: Jójárt-Laczkovich, O., et al., Investigation of recry
powder diffraction, European Journal of Pharmaceutical Sciences (2016),Eq. (1) were in good agreement (r2 N 0.992) with the experimental
points (Fig. 3).
The sigmoidal curves showed that increased temperature acceler-
ates the recrystallization and reduces the crystallization half-time. To
acquire information about the velocity of the process and the dimen-
sions of crystal growth, the parameters K and n were determined by
using the linearized Avrami equation (Eq. (3)) (Fig. 4) and the activa-
tion energy was calculated via the logarithmic form of the Arrhenius
model (Eq. (5)) (Table 7).3.2.2. Analysis of samples stored in hygrostats (XRPD)
To the comparison study amorphous samples were stored for
28 days at 40 °C and 60 °C in 3 hygrostats each, where the RH had
been set to 30%, 40% and 50%. The fractions of recrystallized trehalose
were measured at different times during the 28 days of storage. The
conventional XRPD analysis showed, that the samples stored at 40 °C,
30% and 40% RH, and at 60 °C, 30% RH remained amorphous. The sam-
ples stored at 40 °C, 50% RH recrystallized in the dihydrate form. The
storage conditions at 60 °C, 40% RH, resulted in recrystallization of the
anhydrous form, and in the sample stored at 60 °C, 50% RH, both poly-
morphs appeared, the h-form (dihydrate) and the β-form (anhydrous)
(Fig. 5).
Fig. 5B shows that the stripe at 8.531° 2θ disappears after storage for
14 days, and there is a polymorph conversion of trehalose dihydrate
into the anhydrous form, conﬁrmed by the characteristic thick stripe
at 6.572° 2θ. Fig. 5A and C do not indicate any polymorph conversion.
The diffractograms measured after 28 days storage are shown in Fig. 6.
The degree of crystallinity of the recrystallized polymorphs was cal-
culated by evaluating the diffractograms in Fig. 6 according to the MLR
model. The results showed that amorphous fractions remained in the
samples, but decreased at higher temperature and RH (Table 5).
By means of the 28-days stability tests, the different recrystallized
polymorph forms can be detected and quantiﬁed. The results showed
that, at 40 °C and 50% RH the dihydrate was detected, but the bulk of
the investigated sample remained amorphous. Storage at 60 °C and
40% RH resulted in the appearance of the anhydrous form and only a
minor proportion of the sample remained amorphous. At 60 °C and
50% RH, both polymorphic forms were detected and almost the whole
sample recrystallized. This conventional method is often used as a
long-term stability test in the development of a drug delivery system.Quantity (%)
-form) Amorphous Dihydrate (h-form) Anhydrous (β-form)
100 0 0
100 0 0
63.1 36. 9 0
100 0 0
25.5 0 74.5
0.4 58.2 41.5
stallization of amorphous trehalose through hot-humidity stage X-ray
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Table 7
Avrami parameters and activation energy of recrystallization investigated with HH-XRPD
and DSC.
Method t (°C) n K Ea (kJ mol−1)
HH-XRPD 40 3.373 5.79E-04 47.215
60 3.566 1.70E-03
70 3.934 2.84E-03
DSC 40 3.378 1.69E-03 41.645
60 2.989 5.98E-03
70 3.156 6.29E-03
Fig. 8. Determination of Avrami parameters n and K from DSC data.
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The amount of recrystallized trehalose dihydrate was calculated
from the integral of the endothermic peaks at 108 °C, which is themelt-
ing point of trehalose dehydrate β-form. Table 6 shows the enthalpy
changes (ΔH) of melting and the calculated crystalline fraction (α) at
different temperature increasing the RH.
The amount of crystalline fractions showed, that the recrystallization
of the amorphous sample is more signiﬁcant with increasing RH and at
70% RH total recrystallization of the samples occurred at all 3 tempera-
tures. Comparison of these results with those in Table 4 shows that DSC
andHH-XRPDmeasurements correlate well.With thismethod, only the
fraction of recrystallized trehalose dihydrate can be determined. Since
the anhydrous form has high melting point, the dihydrate form is con-
versed into the anhydrous form resulting in false measurement data.
However, the method can be used for fast stability testing during the
preformulation.
The crystalline fractions calculated from theDSC data (Table 6)were
plotted against time for each temperature with r2 N 0.983 (Fig. 7).
The sigmoidal curves showed that increased temperature acceler-
ates the recrystallization, and reduces the crystallization half-time. To
acquire information about the velocity of the process and the dimen-
sions of crystal growth, the Avrami parameters should be determined.
The parameters K and n were determined by using the linearized
Avrami equation (Eq. (3)). A plot of ln [-ln (1-α)] against ln (t) yields
a straight line with slope n and intercept ln K (Fig. 8). The activation en-
ergy was calculated via the logarithmic form of the Arrhenius model
(Eq. (5)). Table 6 shows the parameters of the recrystallization process.
The values of rate constant K show that increasing temperature ac-
celerates the recrystallization process. There are differences between
the measurement results of the two methods, but the results correlate
well. Comparison of the HH-XRPD data with the DSC measurements
demonstrates that increasing temperature accelerates the recrystalliza-
tion and reduces the crystallization half-time. The parameters K and n
were determined by using the linearized Avrami equation (Eq. (3))
(Fig. 8).Fig. 7. Crystallization kinetics by ﬁtting the Avrami equation to the DSC data.
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In the comparison study the three analytical methods (HH-XRPD,
XRPD, DSC)were used to investigate the recrystallization of amorphous
trehalose. The focus of this work was to suggest such method, which is
sensitive and rapid to predict the recrystallization process in the
preformulation study.
HH-XRPD was used to investigate the effects of temperature and
rapid RH changes. Different RH conditions resulted in different crystal-
line forms of trehalose, whichmeans that recrystallization can start dur-
ing the process of the investigation. In this way, the control of
crystallinity is necessary. The measurement demonstrated that the re-
crystallization began at 40 and 60 °C up to 45% RH and at 70 °C up to
30% RH into dihydrate form. At 70 °C up to 60% RH, the anhydrous
form of trehalose appeared too. It could be concluded that the temper-
ature and RH dependence of recrystallization are determining factors.
This can be expressed in a numerical relationship by the Avrami and Ar-
rhenius equations. HH-XRPD is a good choice for gaining a good estima-
tion over a few hours about the samples behaviour, which could be
reﬂected on the results of a conventional stability test.
The conventional storage at different temperatures and RH gave in-
formation about the recrystallized polymorphs. Over the course of
28 days, both RH and temperature changes can cause the recrystalliza-
tion of amorphous trehalose. The dihydrate form was detected at
40 °C, 50% RH. Storage at 60 °C, 40% RH resulted in the appearance of
the anhydrous form and at 60 °C, 50% RH both polymorphic forms
were detected. In this light, the suitable choice of the storage conditions
can protect the amorphous trehalose samples from crystallization.
By carrying out the DSC measurements at different temperatures,
the fraction of recrystallized trehalose dihydrate can be determined.
The degree of crystallinity of trehalose dihydrate determined by DSC
correlated well with the HH-XRPD measurements.
It could be concluded that HH-XRPD is faster than other convention-
al techniques and a good prediction for the recrystallization of amor-
phous compounds during preformulation, moreover the physical
changes could be studied on one sample.References
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